Skip to main content

Advertisement

Log in

Does difluoromethylornithine prevent recurrence in low-risk superficial bladder cancer?

  • Practice Point
  • Published:

From Nature Clinical Practice Urology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Busby JE and Kamat AM (2005) Chemoprevention for bladder cancer. J Urol 176: 1914–1920

    Article  Google Scholar 

  2. Donat SM et al. (2004) Efficacy of office fulguration for recurrent low grade papillary bladder tumors. J Urol 171: 636–639

    Article  Google Scholar 

  3. Yossepowitch O et al. Risks and benefits of surveillance cystoscopy for recurrent bladder tumors. J Urol, in press

  4. Fleshner N et al. (1999) Influence of smoking status on disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder. Cancer 86: 2192–2194

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Mandy Aujla, Assistant Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Herr, H. Does difluoromethylornithine prevent recurrence in low-risk superficial bladder cancer?. Nat Rev Urol 4, 240–241 (2007). https://doi.org/10.1038/ncpuro0753

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0753

  • Springer Nature Limited

Navigation